WO2001018545A2 - Verfahren zur identifizierung von bindungspartnern mit positions-spezifischen arrays - Google Patents
Verfahren zur identifizierung von bindungspartnern mit positions-spezifischen arrays Download PDFInfo
- Publication number
- WO2001018545A2 WO2001018545A2 PCT/DE2000/003071 DE0003071W WO0118545A2 WO 2001018545 A2 WO2001018545 A2 WO 2001018545A2 DE 0003071 W DE0003071 W DE 0003071W WO 0118545 A2 WO0118545 A2 WO 0118545A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- array
- carrier material
- peptide array
- bound
- cell lysate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/04—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components
Definitions
- the present invention relates to a method for the mass spectrometric identification of binding partners with position-specific arrays.
- the function consists essentially of the dynamic appearance and disappearance of the proteins and their interaction with ligands, which are also proteins in the majority.
- the regulation of the function of proteins is an extremely complicated process that is influenced at various levels, e.g. through post-translational modifications, their half-lives, compartmentalization, but also dynamic changes in the tertiary structure.
- the investigation of the function and the interactions of all proteins within a cell is called “proteomics" (Dove, 1999; Hochstrasser, 1998), the entirety of all proteins of a cell is called a "proteome”. This area of research will have a tremendous impact on the identification of drug targets, drug tailoring and drug discovery.
- the method currently used almost exclusively to display the proteome of a cell is two-dimensional polyacrylamide gel electrophoresis (2D-PAGE).
- the proteins are separated in the first dimension by isoelectric focusing.
- No. 5,821,047 describes a further current approach for the identification of cellular interacting partners, the so-called “phage display”.
- the method comprises the fusion of a protein to be examined to the carboxy-terminal domain of the Gen III coat protein of the filamentous phage M13 this fusion protein presented on the surface of phage M13 is then screened for new ligands of the protein to be examined.
- a further embodiment of the method according to the invention is characterized in that the cell lysate is used together with at least one defined cofactor.
- the cell lysate is used together with at least one defined cofactor.
- proteins or metal ions can be used as cofactors.
- a preferred method according to the invention is further characterized in that the peptides used for the peptide array are between 3 and 30 amino acids long. Peptides between 6 and 15 amino acids in length are preferred, peptides with 13 amino acids in length are particularly preferred.
- An embodiment according to the invention is particularly preferred in which the peptides used for the peptide array are fixed to the carrier material via a linker. This linker can be protease sensitive or chemically cleavable.
- Another preferred method according to the invention is characterized in that the peptide array used is an SPOT peptide array.
- protein not bound to the peptide array can be removed by washing with a buffer or by precipitation.
- One embodiment of the method according to the invention is characterized in that the protein (s) bound to the peptide array are detached from the carrier material before the protease treatment and are then subjected to gel electrophoresis.
- ⁇ -blockers cardiovascular active compounds, antarrhythmics, antihistamines, tranquilizers, H 2 blockers, acidose therapeutics, aminoglycoside antibiotics, amoebicides, anesthetics, analgesics, androgens, antacids, anthel intica, antiallergics, antiandrogenics, antibiotics, antibiotics, antibiotics, antibiotics, antibiotics Anticonvulsants, antidotes, antiemetics, antifibrinolytics, antihypertensives, antihypertonica, antihypotonica, antimalarials, antimycotics, antiparkinson drugs, antiphlogistics, antipsoriatics, antipyretics, antirhematics, antiscabiasa, antitosis drugs, antitosis drugs, antitosis drugs Bronchiolytics, calcium antagonists, car- diotonica, cerebrotonica, chemotherapeutics, cholesterol-lowering agents, cytostatics,
- FIG. 4 shows a MALDI mass fingerprint of spot E2 (thyrosine protein kinase JAK3).
- FIG. 5 shows the MS fit calculation of spot E2 from FIG. 4
- FIG. 6 shows the 35 S activity after incubation of a library of 1600 dipeptoids with 35 S-methionine-labeled cell lysate.
- EPO erythropoietin receptor
- the intracellular domains of the cytokine receptors are known to be composed of structural modules for the binding of specific cellular signal proteins. It is believed that the ability to interact with certain targets causes competence and specificity in the regulation of gene expression.
- cellulose-bound peptides produced by spot synthesis were used.
- Cellular proteins of the o U) f. MP 1 c ⁇ o c ⁇ O c ⁇ O c ⁇
- JAK2 immunoprecipitated with strongly carboxy-terminally truncated receptor forms.
- mutations in the region near the membrane eliminate JAK2 binding and function equally.
- a second interaction site was identified in a more distal part of the receptor.
- SHPl a tyrosine phosphatase, which is known to be functionally involved in the EPO-induced signal cascade, binds with high affinity to the same peptides, amino acids 386-398 and also to the proximal membrane amino acid sequence as for JAK2.
- the phosphatase containing the SH2 domain has previously been shown to bind to phosphotyrosine 429 in the carboxy-terminal part of the activated receptor.
- these proteins were stained, digested enzymatically in-gel, the fragments isolated and subjected to mass spectrometry. The purity and amount of the proteins present in the gel bands was absolutely sufficient to identify the protein species obtained from the peptide spots via peptide mass fingerprints.
- Some of these proteins have not been described for functions in connection with EPOR.
- the Janus kinase JAK3 which is known to be involved in IL-2, 4, 7, 9, 15 signal cascades, has been identified as a binding partner of peptides from the EPOR sequence ( Figures 4 and 5). Further studies on the functional relevance of the identified proteins follow.
- the gel pieces were swollen with 10 ⁇ l of 5 mM ammonium bicarbonate with 300 ng of trypsin. After 60 min, 5 ⁇ l of 5 mM ammonium bicarbonate was added to keep the gel pieces moist during the tryptic digestion (37 ° C., above
- MALDI mass spectrometry and database search The mass spectrometric measurements were carried out on a Voyager-DE STR BioSpectrometry workstation MALDI-TOF mass spectrometer (Perseptive Biosystems, Inc.). 2 ⁇ l of the analysis solution was dissolved with 2 ⁇ l alpha-cyano-4-hydroxycinnamic acid (4-HCCA) matrix solution, consisting of 10 mg matrix in 1 ml 0.3% TFA in acetonitrile water (1: 1, v / v), mixed. 1 ⁇ l of the mixture obtained was applied to the sample plate. The samples were air dried at room temperature (24 ° C).
- 4-HCCA alpha-cyano-4-hydroxycinnamic acid
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00965834A EP1212622A2 (de) | 1999-09-03 | 2000-09-01 | Verfahren zur identifizierung von bindungspartnern mit positions-spezifischen arrays |
DE10082703T DE10082703D2 (de) | 1999-09-03 | 2000-09-01 | Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays (kein Eintritt in die nationale Phase erfolgt) |
HU0203074A HUP0203074A2 (hu) | 1999-09-03 | 2000-09-01 | Eljárás kötőpartnerek azonosítására helyspecifikus tömbökkel |
PL00353995A PL353995A1 (en) | 1999-09-03 | 2000-09-01 | Method for identifying binding partners with position-specific arrays |
AU76442/00A AU7644200A (en) | 1999-09-03 | 2000-09-01 | Method for identifying binding partners with position-specific arrays |
CA002386607A CA2386607A1 (en) | 1999-09-03 | 2000-09-01 | Method for identifying binding partners with position-specific arrays |
JP2001522083A JP2003511652A (ja) | 1999-09-03 | 2000-09-01 | 位置特異性配列を有する結合パートナーの特定方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19943743A DE19943743C2 (de) | 1999-09-03 | 1999-09-03 | Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays |
DE19943743.2 | 1999-09-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001018545A2 true WO2001018545A2 (de) | 2001-03-15 |
WO2001018545A3 WO2001018545A3 (de) | 2001-09-13 |
Family
ID=7921806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2000/003071 WO2001018545A2 (de) | 1999-09-03 | 2000-09-01 | Verfahren zur identifizierung von bindungspartnern mit positions-spezifischen arrays |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1212622A2 (de) |
JP (1) | JP2003511652A (de) |
AU (1) | AU7644200A (de) |
CA (1) | CA2386607A1 (de) |
CZ (1) | CZ2002660A3 (de) |
DE (2) | DE19943743C2 (de) |
HU (1) | HUP0203074A2 (de) |
PL (1) | PL353995A1 (de) |
WO (1) | WO2001018545A2 (de) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1319954A1 (de) * | 2001-12-12 | 2003-06-18 | Centre National de Genotypage | Verfahren zur Proteinanalyse durch Protein bindende Arrays |
EP1483578A2 (de) * | 2002-03-01 | 2004-12-08 | Receptors LLC | Künstliche rezeptoren, bausteine und verfahren |
WO2006029383A2 (en) * | 2004-09-11 | 2006-03-16 | Receptors Llc | Combinatorial artificial receptors including peptide building blocks |
US7469076B2 (en) | 2003-09-03 | 2008-12-23 | Receptors Llc | Sensors employing combinatorial artificial receptors |
US7504365B2 (en) | 2004-09-03 | 2009-03-17 | Receptors Llc | Combinatorial artificial receptors including tether building blocks |
US7960311B2 (en) | 2002-09-16 | 2011-06-14 | Receptors Llc | Methods employing combinatorial artificial receptors |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10141464A1 (de) * | 2001-08-23 | 2004-03-04 | Genprofile Ag I.Ins. | Sequenzvarianten des für neuropsychiatrische Krankheiten verantwortlichen Gens 22444 und deren Verwendung |
US20030228709A1 (en) * | 2002-03-25 | 2003-12-11 | Kozlowski Roland Zbignieiw | Arrays |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0742438A2 (de) * | 1995-05-10 | 1996-11-13 | Bayer Corporation | Screening von Kombinations-Peptidbibliotheken zur Auswahl von Peptidligand zur Verwendung in Affinitätsreinigung von Zielproteinen |
WO1997043301A2 (en) * | 1996-05-10 | 1997-11-20 | Novartis Ag | Identification of members of combinatorial libraries by mass spectrometry |
WO1999012040A2 (en) * | 1997-09-02 | 1999-03-11 | Sequenom, Inc. | Mass spectrometric detection of polypeptides |
WO1999035502A1 (en) * | 1998-01-08 | 1999-07-15 | The University Of Liverpool | Use of mass fingerprinting for identification of protein affinity ligands |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750373A (en) * | 1990-12-03 | 1998-05-12 | Genentech, Inc. | Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants |
DE4027675C2 (de) * | 1990-08-31 | 1997-05-07 | Biotechnolog Forschung Gmbh | Verfahren zur parallelen Herstellung von trägergebundenen oder freien Peptiden, trägergebundene Peptide und ihre Verwendung |
-
1999
- 1999-09-03 DE DE19943743A patent/DE19943743C2/de not_active Expired - Fee Related
-
2000
- 2000-09-01 WO PCT/DE2000/003071 patent/WO2001018545A2/de not_active Application Discontinuation
- 2000-09-01 EP EP00965834A patent/EP1212622A2/de not_active Withdrawn
- 2000-09-01 DE DE10082703T patent/DE10082703D2/de not_active Expired - Lifetime
- 2000-09-01 CA CA002386607A patent/CA2386607A1/en not_active Abandoned
- 2000-09-01 HU HU0203074A patent/HUP0203074A2/hu unknown
- 2000-09-01 CZ CZ2002660A patent/CZ2002660A3/cs unknown
- 2000-09-01 AU AU76442/00A patent/AU7644200A/en not_active Abandoned
- 2000-09-01 JP JP2001522083A patent/JP2003511652A/ja active Pending
- 2000-09-01 PL PL00353995A patent/PL353995A1/xx not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0742438A2 (de) * | 1995-05-10 | 1996-11-13 | Bayer Corporation | Screening von Kombinations-Peptidbibliotheken zur Auswahl von Peptidligand zur Verwendung in Affinitätsreinigung von Zielproteinen |
WO1997043301A2 (en) * | 1996-05-10 | 1997-11-20 | Novartis Ag | Identification of members of combinatorial libraries by mass spectrometry |
WO1999012040A2 (en) * | 1997-09-02 | 1999-03-11 | Sequenom, Inc. | Mass spectrometric detection of polypeptides |
WO1999035502A1 (en) * | 1998-01-08 | 1999-07-15 | The University Of Liverpool | Use of mass fingerprinting for identification of protein affinity ligands |
Non-Patent Citations (3)
Title |
---|
M. A. KELLY ET AL.: "Characterization of SH2-ligand interactions via library affinity selection with mass spectrometric detection." BIOCHEMISTRY., Bd. 35, Nr. 36, 1996, Seiten 11747-11755, XP002062459 AMERICAN CHEMICAL SOCIETY. EASTON, PA., US ISSN: 0006-2960 * |
P. L. COURCHESNE ET AL.: "Identification of proteins by matrix-assisted laser desorption/ionization mass spectrometry using peptide and fragment ion masses (from "2D Proteome Analysis Protocols, Ed. A. J. Link)" METHODS IN MOLECULAR BIOLOGY, Bd. 112, 1999, Seiten 487-511, XP002103063 * |
S. R. PENNINGTON ET AL.: "Proteome analysis: from protein characterization to biological function." TRENDS IN CELL BIOLOGY., Bd. 7, April 1997 (1997-04), Seiten 168-173, XP002103064 ELSEVIER SCIENCE LTD., XX ISSN: 0962-8924 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1319954A1 (de) * | 2001-12-12 | 2003-06-18 | Centre National de Genotypage | Verfahren zur Proteinanalyse durch Protein bindende Arrays |
WO2003050544A2 (en) * | 2001-12-12 | 2003-06-19 | Consortium National De Recherche En Genomique (Cnrg) | Methods for protein analysis using protein capture arrays |
WO2003050544A3 (en) * | 2001-12-12 | 2003-11-20 | Consortium Nat De Rech En Geno | Methods for protein analysis using protein capture arrays |
US7504364B2 (en) | 2002-03-01 | 2009-03-17 | Receptors Llc | Methods of making arrays and artificial receptors |
JP2005519124A (ja) * | 2002-03-01 | 2005-06-30 | レセプターズ エルエルシー | 人工受容体、ビルディングブロック、および方法 |
EP1483578A4 (de) * | 2002-03-01 | 2007-06-06 | Receptors Llc | Künstliche rezeptoren, bausteine und verfahren |
EP1483578A2 (de) * | 2002-03-01 | 2004-12-08 | Receptors LLC | Künstliche rezeptoren, bausteine und verfahren |
US7960311B2 (en) | 2002-09-16 | 2011-06-14 | Receptors Llc | Methods employing combinatorial artificial receptors |
US7469076B2 (en) | 2003-09-03 | 2008-12-23 | Receptors Llc | Sensors employing combinatorial artificial receptors |
US7504365B2 (en) | 2004-09-03 | 2009-03-17 | Receptors Llc | Combinatorial artificial receptors including tether building blocks |
US7884052B2 (en) | 2004-09-03 | 2011-02-08 | Receptors Llc | Combinatorial artificial receptors including tether building blocks on scaffolds |
WO2006029383A2 (en) * | 2004-09-11 | 2006-03-16 | Receptors Llc | Combinatorial artificial receptors including peptide building blocks |
WO2006029383A3 (en) * | 2004-09-11 | 2006-11-30 | Receptors Llc | Combinatorial artificial receptors including peptide building blocks |
US7985715B2 (en) | 2004-09-11 | 2011-07-26 | Receptors Llc | Combinatorial artificial receptors including peptide building blocks |
Also Published As
Publication number | Publication date |
---|---|
WO2001018545A3 (de) | 2001-09-13 |
DE19943743A1 (de) | 2001-03-15 |
JP2003511652A (ja) | 2003-03-25 |
EP1212622A2 (de) | 2002-06-12 |
AU7644200A (en) | 2001-04-10 |
PL353995A1 (en) | 2003-12-15 |
CZ2002660A3 (cs) | 2002-10-16 |
HUP0203074A2 (hu) | 2002-12-28 |
DE10082703D2 (de) | 2002-02-14 |
DE19943743C2 (de) | 2002-02-07 |
CA2386607A1 (en) | 2001-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Baggerman et al. | Gel-based versus gel-free proteomics: a review | |
James | Protein identification in the post-genome era: the rapid rise of proteomics | |
DE69912444T3 (de) | Schnelle quantitative analyse von proteinen oder proteinfunktionen in komplexen gemischen | |
DE60211744T3 (de) | Massenspektrometrie-verfahren | |
DE60204669T2 (de) | Verfahren und vorrichtung zur gel-freien qualitativen proteomanalyse und deren verwendungen | |
DE112011102286B4 (de) | Massenspektrometrische Quantifizierung von Analyten unter Verwendung eines Universalreporters | |
DE69817211T2 (de) | Charakterisierung von polypeptiden | |
DE602005004902T2 (de) | Künstliches Protein, Verfahren für absolute Quantifizierung der Proteine und seine Benutzung | |
DE602005001302T2 (de) | Bestimmung von analytcharakteristika auf der grundlage von bindungseigenschaften | |
CN102395886B (zh) | 用于对修饰的肽进行定量的方法 | |
DE60320207T2 (de) | N- oder C-terminale Peptid-Auswahlmethode für Proteomics | |
WO2000067017A9 (en) | Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy | |
EP1212622A2 (de) | Verfahren zur identifizierung von bindungspartnern mit positions-spezifischen arrays | |
DE19802576B4 (de) | Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern | |
DE60119580T2 (de) | Schnelle und quantitative proteomanalyse und damit zusammenhängende verfahren | |
EP1330655B1 (de) | Verfahren zur analyse von proteinen | |
Khan et al. | Proteomics by mass spectrometry—Go big or go home? | |
US20030175804A1 (en) | Macromolecule detection | |
DE69927668T2 (de) | Massenfingerabdrucken und seiner verwendung zur identifizierung von protein-affinitätsliganden | |
DE60317904T2 (de) | Ein verfahren zum identifizierung von arzneimittelzielen | |
DE10081888B4 (de) | Verfahren zur mehrdimensionalen Analyse eines Proteoms | |
EP1504267B1 (de) | Festphasenassisitierte spektroskopische und spektrometrische analyse komplexer biopolymergemische | |
DE102006041644B4 (de) | Verfahren zur Detektion von Modifikationen in einem Protein oder Peptid | |
Groenen et al. | Teaching molecular genetics: Chapter 3–Proteomics in nephrology | |
Zybailov et al. | Mass spectrometry-based methods of proteome analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WD | Withdrawal of designations after international publication |
Free format text: DE |
|
REF | Corresponds to |
Ref document number: 10082703 Country of ref document: DE Date of ref document: 20020214 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10082703 Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2002-660 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2386607 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000965834 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10070003 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000965834 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2002-660 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000965834 Country of ref document: EP |